{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:47:29Z","timestamp":1792198049472,"version":"4.4.0"},"reference-count":30,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background\/Objectives: Bladder cancer is a prevalent urinary system malignancy and urinary cytology is widely used for its screening and follow-up. A novel diagnostic tool called Bladder Epicheck\u00ae (BE) is increasingly being used for monitoring the recurrence of non-muscle-invasive bladder cancer (NMIBC). The simultaneous use of BE and urinary cytology can increase the diagnostic performances in the follow-up of bladder neoplasms. Methods: In this multicenter study, we retrospectively evaluated the data of 322 patients in follow-up for a high-grade bladder carcinoma over a six-year period (from January 2018 to March 2024). The diagnostic performances of both cytology and BE and their combination were calculated using histology as gold standard. Results: Recurrences were diagnosed as high-grade urothelial carcinoma NMIBC in 18 cases, low-grade papillary NMIBC in 8 cases, and carcinoma in situ (CIS) in 4 cases. Cytological analysis correctly identified 26 out of 30 carcinomas, while 286 were correctly diagnosed as negative results. BE correctly identified 25 out of 30 carcinomas, 285 were correctly diagnosed as negative results. The combination of BE and urinary cytology correctly identified 29 out of 30 carcinomas, while 289 were correctly diagnosed as negative results. Conclusions: The combination of BE and cytology could be the most effective approach for follow-up diagnosis in patients with high-grade NMIBC, reducing unnecessary invasive procedures.<\/jats:p>","DOI":"10.3390\/diseases12090219","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T09:43:13Z","timestamp":1726652593000},"page":"219","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The Simultaneous Use of Bladder Epicheck\u00ae and Urinary Cytology Can Improve the Sensitivity and Specificity of Diagnostic Follow-Up of Urothelial Lesions: Up-to-Date Data from a Multi-Institutional Cohort"],"prefix":"10.3390","volume":"12","author":[{"given":"Ludovica","family":"Pepe","sequence":"first","affiliation":[{"name":"Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1132-1761","authenticated-orcid":false,"given":"Vincenzo","family":"Fiorentino","sequence":"additional","affiliation":[{"name":"Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-7174","authenticated-orcid":false,"given":"Cristina","family":"Pizzimenti","sequence":"additional","affiliation":[{"name":"Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Riganati","sequence":"additional","affiliation":[{"name":"Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5806-2307","authenticated-orcid":false,"given":"Mariausilia","family":"Franchina","sequence":"additional","affiliation":[{"name":"Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Micali","sequence":"additional","affiliation":[{"name":"Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Russotto","sequence":"additional","affiliation":[{"name":"Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ieni","sequence":"additional","affiliation":[{"name":"Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tuccari","sequence":"additional","affiliation":[{"name":"Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Fadda","sequence":"additional","affiliation":[{"name":"Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pierconti","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and Public Health, Catholic University of the Sacred Heart, Agostino Gemelli IRCCS University Hospital Foundation, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6260-6310","authenticated-orcid":false,"given":"Maurizio","family":"Martini","sequence":"additional","affiliation":[{"name":"Department of Human Pathology in Adult and Developmental Age \u201cGaetano Barresi\u201d, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Dobruch, J., and Oszczud\u0142owski, M. (2021). Bladder Cancer: Current Challenges and Future Directions. Medicina, 57.","DOI":"10.3390\/medicina57080749"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: Epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Fiorentino, V., Pizzimenti, C., and Franchina, M. (2023). Bladder Epicheck\u00ae Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241512489"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s13193-023-01864-z","article-title":"Impact of Implementing Paris System on Diagnostic Precision and Management of Urinary Bladder Neoplasms","volume":"15","author":"Arora","year":"2024","journal-title":"Indian. J. Surg. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ng.907","article-title":"Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder","volume":"43","author":"Gui","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cncy.22657","article-title":"DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group","volume":"131","author":"Pierconti","year":"2023","journal-title":"Cancer Cytopathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.urolonc.2020.11.014","article-title":"Novel urinary biomarkers ADXBLADDER and Bladder Epicheck\u00ae for diagnostics of bladder cancer: A review","volume":"39","author":"Wolfs","year":"2021","journal-title":"Urol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/cncy.22246","article-title":"Comparison of 2 new real-time polymerase chain reaction-based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancer","volume":"128","author":"Trenti","year":"2020","journal-title":"Cancer Cytopathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cncy.22152","article-title":"Diagnostic predictive value of the Bladder Epicheck\u00ae test in the follow-up of patients with non-muscle-invasive bladder cancer","volume":"127","author":"Trenti","year":"2019","journal-title":"Cancer Cytopathol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Baekelandt, L., Akand, M., and VAN DEN Broeck, T. (Minerva Urol. Nephrol., 2024). Transforming UTUC diagnostics: The potential of Bladder Epicheck\u00ae in clinical practice, Minerva Urol. Nephrol., online ahead of print.","DOI":"10.23736\/S2724-6051.24.06059-2"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ca\u00f1o Velasco, J., Artero Fullana, S., and Polanco Pujol, L. (Actas Urol. Esp. (Engl. Ed.), 2024). Use of Bladder Epicheck\u00ae in the follow-up of high-risk non-muscle-invasive Bladder cancer: A systematic literature review, Actas Urol. Esp. (Engl. Ed.), epub ahead of print.","DOI":"10.1016\/j.acuroe.2024.05.004"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.euros.2024.02.018","article-title":"Clinical Trial Protocol for \u201cReplace Cysto\u201d: Replacing Invasive Cystoscopy with Urine Testing for Non-muscle-invasive Bladder Cancer Surveillance-A Multicenter, Randomized, Phase 2 Healthcare Delivery Trial Comparing Quality of Life During Cancer Surveillance with Xpert Bladder Cancer Monitor or Bladder Epicheck\u00ae Urine Testing Versus Frequent Cystoscopy","volume":"63","author":"Schroeck","year":"2024","journal-title":"Eur. Urol. Open Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"131.e17","DOI":"10.1016\/j.urolonc.2020.06.018","article-title":"The combination cytology\/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?","volume":"39","author":"Pierconti","year":"2021","journal-title":"Urol. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2017.07.016","article-title":"The burden of cystoscopic bladder cancer surveillance: Anxiety, discomfort, and patient preferences for decision making","volume":"108","author":"Koo","year":"2017","journal-title":"Urology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur. Urol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"108.e19","DOI":"10.1016\/j.urolonc.2021.11.013","article-title":"The Bladder Epicheck\u00ae test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma","volume":"40","author":"Pierconti","year":"2022","journal-title":"Urol. Oncol."},{"key":"ref_17","first-page":"188","article-title":"La version 2022 du Syst\u00e8me de Paris: Quoi de neuf? The Paris System, 2022 edition: What is new?","volume":"44","year":"2024","journal-title":"Ann. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/cyt.13189","article-title":"The inclusion of nuclear area improves the paris system for reporting urinary cytology","volume":"34","author":"Tanaka","year":"2023","journal-title":"Cytopathology"},{"key":"ref_19","first-page":"412","article-title":"Urine cytology and adjunct markers for detection and surveillance of bladder cancer","volume":"2","author":"Sullivan","year":"2010","journal-title":"Am. J. Transl. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cncy.22539","article-title":"Impact of bacillus calmette-guerin intravesical therapy on the diagnostic efficacy of the paris system for reporting urinary cytology in patients with high-grade bladder cancer","volume":"130","author":"Hermans","year":"2022","journal-title":"Cancer Cytopathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.euo.2018.06.011","article-title":"Performance of the Bladder Epicheck\u2122 Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial","volume":"1","author":"Witjes","year":"2018","journal-title":"Eur. Urol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Ye, F., Liang, Y., Hu, J., and Hu, Y. (2021). DNA Methylation Modification Map to Predict Tumor Molecular Subtypes and Efficacy of Immunother-apy in Bladder Cancer. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.760369"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Pierconti, F., Rossi, E.D., and Fiorentino, V. (2023). Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result. Biomedicines, 11.","DOI":"10.3390\/biomedicines11123288"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e43024","DOI":"10.7554\/eLife.43024","article-title":"Epigenetic regulation of mammalian hedgehog signaling to the stroma determines the molecular subtype of bladder cancer","volume":"8","author":"Kim","year":"2019","journal-title":"Elife"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1016\/j.clgc.2022.03.009","article-title":"The Role of Bladder Epicheck\u00ae Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer","volume":"20","author":"Ragonese","year":"2022","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Picard, L.C., Rich, F.J., and Kenwright, D.N. (2024). Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer. Biochim. Biophys. Acta Rev. Cancer, 1879.","DOI":"10.1016\/j.bbcan.2024.189123"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000030495","article-title":"Cytological changes induced by intravesical bacillus Calmette-Gu\u00e9rin therapy for superficial bladder cancer","volume":"64","author":"Takashi","year":"2000","journal-title":"Urol. Int."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Guldhammer, C.S., V\u00e1squez, J.L., and Kristensen, V.M. (2023). Cystoscopy Accuracy in Detecting Bladder Tumors: A Prospective Video-Confirmed Study. Cancers, 16.","DOI":"10.3390\/cancers16010160"},{"key":"ref_29","first-page":"474","article-title":"Adverse effects of cystoscopy and its impact on patients\u2019 quality of life and sexual performance","volume":"6","author":"Stav","year":"2004","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.euf.2023.08.002","article-title":"The Diagnostic Accuracy of Cystoscopy for Detecting Bladder Cancer in Adults Presenting with Haematuria: A Systematic Review from the European Association of Urology Guidelines Office","volume":"10","author":"Devlies","year":"2024","journal-title":"Eur. Urol. Focus"}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/12\/9\/219\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:58:14Z","timestamp":1760111894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/12\/9\/219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["diseases12090219"],"URL":"https:\/\/doi.org\/10.3390\/diseases12090219","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]}}}